abbott diabetes care limited
abbott diabetes care limited Company Information
Company Number
02548046
Website
www.abbott.comRegistered Address
windrush park, range road, witney, oxon, OX29 0YL
Industry
Manufacture of medical and dental instruments and supplies
Telephone
01993892600
Next Accounts Due
September 2024
Group Structure
View All
Shareholders
abbott laboratories ltd 100%
abbott diabetes care limited Estimated Valuation
The estimated valuation range for abbott diabetes care limited, derived from financial data as of December 2022 and the most recent industry multiples, is between £199.9m to £2.9b
abbott diabetes care limited Estimated Valuation
The estimated valuation range for abbott diabetes care limited, derived from financial data as of December 2022 and the most recent industry multiples, is between £199.9m to £2.9b
abbott diabetes care limited Estimated Valuation
The estimated valuation range for abbott diabetes care limited, derived from financial data as of December 2022 and the most recent industry multiples, is between £199.9m to £2.9b
Get a detailed valuation report, edit figures and unlock valuation multiples.
Abbott Diabetes Care Limited AI Business Plan
In just minutes, we combine Pomanda’s company and industry data with cutting edge Artificial Intelligence to build a comprehensive 27 section business plan. You then have 60 days to tailor the information, decide which sections to include or exclude, and add your own branding logos, images and color scheme to create your perfect plan.
Abbott Diabetes Care Limited Overview
Abbott Diabetes Care Limited is a live company located in witney, OX29 0YL with a Companies House number of 02548046. It operates in the manufacture of medical and dental instruments and supplies sector, SIC Code 32500. Founded in October 1990, it's largest shareholder is abbott laboratories ltd with a 100% stake. Abbott Diabetes Care Limited is a mature, mega sized company, Pomanda has estimated its turnover at £150.4m with healthy growth in recent years.
Upgrade for unlimited company reports & a free credit check
Abbott Diabetes Care Limited Health Check
Pomanda's financial health check has awarded Abbott Diabetes Care Limited a 3.5 rating. We use a traffic light system to show it exceeds the industry average on 5 measures and has 5 areas for improvement. Company Health Check FAQs
5 Strong
1 Regular
5 Weak
Size
annual sales of £150.4m, make it larger than the average company (£14.8m)
£150.4m - Abbott Diabetes Care Limited
£14.8m - Industry AVG
Growth
3 year (CAGR) sales growth of 8%, show it is growing at a faster rate (4.1%)
8% - Abbott Diabetes Care Limited
4.1% - Industry AVG
Production
with a gross margin of 15%, this company has a higher cost of product (37.1%)
15% - Abbott Diabetes Care Limited
37.1% - Industry AVG
Profitability
an operating margin of 224.4% make it more profitable than the average company (5.7%)
224.4% - Abbott Diabetes Care Limited
5.7% - Industry AVG
Employees
with 854 employees, this is above the industry average (72)
854 - Abbott Diabetes Care Limited
72 - Industry AVG
Pay Structure
on an average salary of £61.6k, the company has a higher pay structure (£45.3k)
£61.6k - Abbott Diabetes Care Limited
£45.3k - Industry AVG
Efficiency
resulting in sales per employee of £176.1k, this is equally as efficient (£174.3k)
£176.1k - Abbott Diabetes Care Limited
£174.3k - Industry AVG
Debtor Days
There is insufficient data available for this Key Performance Indicator!
- - Abbott Diabetes Care Limited
- - Industry AVG
Creditor Days
its suppliers are paid after 31 days, this is quicker than average (36 days)
31 days - Abbott Diabetes Care Limited
36 days - Industry AVG
Stock Days
it holds stock equivalent to 27 days, this is less than average (92 days)
27 days - Abbott Diabetes Care Limited
92 days - Industry AVG
Cash Balance
has cash to cover current liabilities for 0 weeks, this is less cash available to meet short term requirements (15 weeks)
0 weeks - Abbott Diabetes Care Limited
15 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 66.5%, this is a higher level of debt than the average (43.8%)
66.5% - Abbott Diabetes Care Limited
43.8% - Industry AVG
abbott diabetes care limited Credit Report and Business Information
Abbott Diabetes Care Limited Competitor Analysis
Perform a competitor analysis for abbott diabetes care limited by selecting its closest rivals and benchmarking them against 12 key performance metrics.
abbott diabetes care limited Ownership
ABBOTT DIABETES CARE LIMITED group structure
Abbott Diabetes Care Limited has no subsidiary companies.
Ultimate parent company
ABBOTT HOLDINGS UNIVERSAL LTD
#0130259
2 parents
ABBOTT DIABETES CARE LIMITED
02548046
abbott diabetes care limited directors
Abbott Diabetes Care Limited currently has 4 directors. The longest serving directors include Mr Christopher Bass (Nov 2016) and Mr Shaun Smith (Oct 2018).
| officer | country | age | start | end | role |
|---|---|---|---|---|---|
| Mr Christopher Bass | 41 years | Nov 2016 | - | Director | |
| Mr Shaun Smith | 58 years | Oct 2018 | - | Director | |
| Mr Paul Kenny | 56 years | Mar 2019 | - | Director | |
| Mrs Alison Davies | United Kingdom | 56 years | Oct 2023 | - | Director |
ABBOTT DIABETES CARE LIMITED financials
Abbott Diabetes Care Limited's latest turnover from December 2022 is £150.4 million and the company has net assets of £260.4 million. According to their latest financial statements, Abbott Diabetes Care Limited has 854 employees and maintains cash reserves of £2.3 million as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
| Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Nov 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | 150,400,000 | 100,642,000 | 102,357,000 | 120,350,000 | 99,999,000 | 72,785,000 | 55,468,000 | 51,923,000 | 48,296,000 | 45,433,000 | 44,076,000 | 42,657,000 | 44,400,000 | 52,319,000 |
| Other Income Or Grants | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost Of Sales | 127,871,000 | 120,638,000 | 106,977,000 | 98,137,000 | 82,393,000 | 72,990,000 | 50,268,000 | 46,835,000 | 43,761,000 | 41,076,000 | 39,821,000 | 38,919,000 | 40,833,000 | 48,236,000 |
| Gross Profit | 22,529,000 | -19,996,000 | -4,620,000 | 22,213,000 | 17,606,000 | -205,000 | 5,200,000 | 5,088,000 | 4,535,000 | 4,357,000 | 4,255,000 | 3,738,000 | 3,567,000 | 4,083,000 |
| Admin Expenses | -314,999,000 | -79,041,000 | -7,569,000 | 34,720,000 | 120,179,000 | 52,880,000 | 31,000 | 2,000 | 23,000 | 40,000 | 41,000 | 42,000 | 42,000 | 0 |
| Operating Profit | 337,528,000 | 59,045,000 | 2,949,000 | -12,507,000 | -102,573,000 | -53,085,000 | 5,169,000 | 5,086,000 | 4,512,000 | 4,317,000 | 4,214,000 | 3,696,000 | 3,525,000 | 4,083,000 |
| Interest Payable | 6,813,000 | 443,000 | 564,000 | 1,869,000 | 630,000 | 161,000 | 304,000 | 310,000 | 187,000 | 246,000 | 387,000 | 341,000 | 358,000 | 708,000 |
| Interest Receivable | 2,879,000 | 56,000 | 364,000 | 0 | 0 | 35,000 | 30,000 | 54,000 | 66,000 | 59,000 | 64,000 | 31,000 | 90,000 | 412,000 |
| Pre-Tax Profit | 333,594,000 | 58,658,000 | 2,749,000 | -14,376,000 | -103,203,000 | -53,211,000 | 4,895,000 | 4,830,000 | 4,391,000 | 4,130,000 | 3,891,000 | 3,386,000 | 3,257,000 | 3,787,000 |
| Tax | -64,705,000 | -2,432,000 | -948,000 | 272,000 | -132,000 | -814,000 | -102,000 | -1,501,000 | -3,413,000 | 592,000 | 427,000 | -1,145,000 | 797,000 | -688,000 |
| Profit After Tax | 268,889,000 | 56,226,000 | 1,801,000 | -14,104,000 | -103,335,000 | -54,025,000 | 4,793,000 | 3,329,000 | 978,000 | 4,722,000 | 4,318,000 | 2,241,000 | 4,054,000 | 3,099,000 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 20,000,000 | 0 |
| Retained Profit | 268,889,000 | 56,226,000 | 1,801,000 | -14,104,000 | -103,335,000 | -54,025,000 | 4,793,000 | 3,329,000 | 978,000 | 4,722,000 | 4,318,000 | 2,241,000 | -15,946,000 | 3,099,000 |
| Employee Costs | 52,632,000 | 50,892,000 | 44,953,000 | 39,568,000 | 35,985,000 | 31,129,000 | 30,135,000 | 27,186,000 | 26,065,000 | 25,700,000 | 25,795,000 | 26,580,000 | 27,425,000 | 30,033,000 |
| Number Of Employees | 854 | 813 | 922 | 825 | 692 | 627 | 553 | 573 | 554 | 516 | 515 | 562 | 544 | 640 |
| EBITDA* | 347,124,000 | 67,695,000 | 9,481,000 | -6,119,000 | -96,361,000 | -47,264,000 | 9,602,000 | 9,097,000 | 8,401,000 | 8,165,000 | 8,559,000 | 7,964,000 | 8,953,000 | 9,274,000 |
* Earnings Before Interest, Tax, Depreciation and Amortisation
| Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Nov 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Tangible Assets | 83,566,000 | 86,667,000 | 88,074,000 | 79,045,000 | 71,226,000 | 59,151,000 | 56,600,000 | 42,165,000 | 38,050,000 | 40,161,000 | 38,091,000 | 40,455,000 | 43,719,000 | 47,009,000 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments & Other | 7,378,000 | 8,162,000 | 0 | 0 | 0 | 514,000 | 1,469,000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Debtors (Due After 1 year) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Fixed Assets | 90,944,000 | 94,829,000 | 88,074,000 | 79,045,000 | 71,226,000 | 59,665,000 | 58,069,000 | 42,165,000 | 38,050,000 | 40,161,000 | 38,091,000 | 40,455,000 | 43,719,000 | 47,009,000 |
| Stock & work in progress | 9,577,000 | 9,157,000 | 6,063,000 | 7,191,000 | 10,713,000 | 4,225,000 | 5,339,000 | 1,455,000 | 870,000 | 556,000 | 0 | 0 | 0 | 0 |
| Trade Debtors | 0 | 0 | 1,725,000 | 0 | 804,000 | 882,000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Group Debtors | 673,534,000 | 298,974,000 | 122,537,000 | 68,686,000 | 32,883,000 | 23,598,000 | 51,221,000 | 47,355,000 | 41,167,000 | 33,958,000 | 39,498,000 | 34,504,000 | 30,764,000 | 36,125,000 |
| Misc Debtors | 1,257,000 | 17,584,000 | 2,684,000 | 6,154,000 | 1,487,000 | 4,784,000 | 3,711,000 | 2,200,000 | 2,148,000 | 4,532,000 | 3,065,000 | 2,315,000 | 2,388,000 | 3,577,000 |
| Cash | 2,296,000 | 3,198,000 | 1,603,000 | 1,249,000 | 3,149,000 | 1,757,000 | 2,378,000 | 1,756,000 | 1,810,000 | 1,415,000 | 2,783,000 | 815,000 | 1,228,000 | 0 |
| misc current assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| total current assets | 686,664,000 | 328,913,000 | 134,612,000 | 83,280,000 | 49,036,000 | 35,246,000 | 62,649,000 | 52,766,000 | 45,995,000 | 40,461,000 | 45,346,000 | 37,634,000 | 34,380,000 | 39,702,000 |
| total assets | 777,608,000 | 423,742,000 | 222,686,000 | 162,325,000 | 120,262,000 | 94,911,000 | 120,718,000 | 94,931,000 | 84,045,000 | 80,622,000 | 83,437,000 | 78,089,000 | 78,099,000 | 86,711,000 |
| Bank overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 53,000 |
| Bank loan | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Trade Creditors | 11,190,000 | 13,948,000 | 13,951,000 | 15,640,000 | 15,323,000 | 8,137,000 | 8,615,000 | 4,099,000 | 3,755,000 | 2,438,000 | 2,017,000 | 3,611,000 | 2,792,000 | 4,399,000 |
| Group/Directors Accounts | 457,119,000 | 406,318,000 | 323,517,000 | 262,132,000 | 210,262,000 | 89,216,000 | 60,368,000 | 43,646,000 | 36,052,000 | 37,893,000 | 20,278,000 | 18,254,000 | 22,229,000 | 10,267,000 |
| other short term finances | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| hp & lease commitments | 35,000 | 45,000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other current liabilities | 48,809,000 | 11,854,000 | 9,931,000 | 11,498,000 | 8,648,000 | 8,234,000 | 8,386,000 | 8,641,000 | 8,939,000 | 5,970,000 | 6,228,000 | 5,033,000 | 4,310,000 | 6,482,000 |
| total current liabilities | 517,153,000 | 432,165,000 | 347,399,000 | 289,270,000 | 234,233,000 | 105,587,000 | 77,369,000 | 56,386,000 | 48,746,000 | 46,301,000 | 28,523,000 | 26,898,000 | 29,331,000 | 21,201,000 |
| loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 25,315,000 | 25,315,000 | 25,315,000 | 25,315,000 |
| hp & lease commitments | 53,000 | 64,000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accruals and Deferred Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| provisions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 36,000 | 0 | 0 | 0 | 710,000 | 1,020,000 | 2,595,000 |
| total long term liabilities | 53,000 | 64,000 | 0 | 0 | 0 | 0 | 0 | 36,000 | 0 | 0 | 25,315,000 | 26,025,000 | 26,335,000 | 27,910,000 |
| total liabilities | 517,206,000 | 432,229,000 | 347,399,000 | 289,270,000 | 234,233,000 | 105,587,000 | 77,369,000 | 56,422,000 | 48,746,000 | 46,301,000 | 53,838,000 | 52,923,000 | 55,666,000 | 49,111,000 |
| net assets | 260,402,000 | -8,487,000 | -124,713,000 | -126,945,000 | -113,971,000 | -10,676,000 | 43,349,000 | 38,509,000 | 35,299,000 | 34,321,000 | 29,599,000 | 25,166,000 | 22,433,000 | 37,600,000 |
| total shareholders funds | 260,402,000 | -8,487,000 | -124,713,000 | -126,945,000 | -113,971,000 | -10,676,000 | 43,349,000 | 38,509,000 | 35,299,000 | 34,321,000 | 29,599,000 | 25,166,000 | 22,433,000 | 37,600,000 |
| Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Nov 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||||||||
| Operating Profit | 337,528,000 | 59,045,000 | 2,949,000 | -12,507,000 | -102,573,000 | -53,085,000 | 5,169,000 | 5,086,000 | 4,512,000 | 4,317,000 | 4,214,000 | 3,696,000 | 3,525,000 | 4,083,000 |
| Depreciation | 9,596,000 | 8,650,000 | 6,532,000 | 6,388,000 | 6,212,000 | 5,821,000 | 4,433,000 | 4,011,000 | 3,889,000 | 3,848,000 | 4,345,000 | 4,268,000 | 5,428,000 | 5,191,000 |
| Amortisation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Tax | -64,705,000 | -2,432,000 | -948,000 | 272,000 | -132,000 | -814,000 | -102,000 | -1,501,000 | -3,413,000 | 592,000 | 427,000 | -1,145,000 | 797,000 | -688,000 |
| Stock | 420,000 | 3,094,000 | -1,128,000 | -3,522,000 | 6,488,000 | -1,114,000 | 3,884,000 | 585,000 | 314,000 | 556,000 | 0 | 0 | 0 | 0 |
| Debtors | 358,233,000 | 189,612,000 | 52,106,000 | 39,666,000 | 5,910,000 | -25,668,000 | 5,377,000 | 6,240,000 | 4,825,000 | -4,073,000 | 5,744,000 | 3,667,000 | -6,550,000 | 39,702,000 |
| Creditors | -2,758,000 | -3,000 | -1,689,000 | 317,000 | 7,186,000 | -478,000 | 4,516,000 | 344,000 | 1,317,000 | 421,000 | -1,594,000 | 819,000 | -1,607,000 | 4,399,000 |
| Accruals and Deferred Income | 36,955,000 | 1,923,000 | -1,567,000 | 2,850,000 | 414,000 | -152,000 | -255,000 | -298,000 | 2,969,000 | -258,000 | 1,195,000 | 723,000 | -2,172,000 | 6,482,000 |
| Deferred Taxes & Provisions | 0 | 0 | 0 | 0 | 0 | 0 | -36,000 | 36,000 | 0 | 0 | -710,000 | -310,000 | -1,575,000 | 2,595,000 |
| Cash flow from operations | -42,037,000 | -125,523,000 | -45,701,000 | -38,824,000 | -101,291,000 | -21,926,000 | 4,464,000 | 853,000 | 4,135,000 | 12,437,000 | 2,133,000 | 4,384,000 | 10,946,000 | -17,640,000 |
| Investing Activities | ||||||||||||||
| capital expenditure | ||||||||||||||
| Change in Investments | -784,000 | 8,162,000 | 0 | 0 | -514,000 | -955,000 | 1,469,000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| cash flow from investments | ||||||||||||||
| Financing Activities | ||||||||||||||
| Bank loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Group/Directors Accounts | 50,801,000 | 82,801,000 | 61,385,000 | 51,870,000 | 121,046,000 | 28,848,000 | 16,722,000 | 7,594,000 | -1,841,000 | 17,615,000 | 2,024,000 | -3,975,000 | 11,962,000 | 10,267,000 |
| Other Short Term Loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long term loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -25,315,000 | 0 | 0 | 0 | 25,315,000 |
| Hire Purchase and Lease Commitments | -21,000 | 109,000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other long term liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| share issue | ||||||||||||||
| interest | -3,934,000 | -387,000 | -200,000 | -1,869,000 | -630,000 | -126,000 | -274,000 | -256,000 | -121,000 | -187,000 | -323,000 | -310,000 | -268,000 | -296,000 |
| cash flow from financing | 46,846,000 | 142,523,000 | 61,616,000 | 51,131,000 | 120,456,000 | 28,722,000 | 16,495,000 | 7,219,000 | -1,962,000 | -7,887,000 | 1,816,000 | -3,793,000 | 12,473,000 | 69,787,000 |
| cash and cash equivalents | ||||||||||||||
| cash | -902,000 | 1,595,000 | 354,000 | -1,900,000 | 1,392,000 | -621,000 | 622,000 | -54,000 | 395,000 | -1,368,000 | 1,968,000 | -413,000 | 1,228,000 | 0 |
| overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -53,000 | 53,000 |
| change in cash | -902,000 | 1,595,000 | 354,000 | -1,900,000 | 1,392,000 | -621,000 | 622,000 | -54,000 | 395,000 | -1,368,000 | 1,968,000 | -413,000 | 1,281,000 | -53,000 |
P&L
December 2022turnover
150.4m
+49%
operating profit
337.5m
+472%
gross margin
15%
-175.39%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
December 2022net assets
260.4m
-31.68%
total assets
777.6m
+0.84%
cash
2.3m
-0.28%
net assets
Total assets minus all liabilities
abbott diabetes care limited company details
company number
02548046
Type
Private limited with Share Capital
industry
32500 - Manufacture of medical and dental instruments and supplies
incorporation date
October 1990
age
34
accounts
Full Accounts
ultimate parent company
previous names
medisense uk limited (August 2005)
medisense (u.k.) holding ltd. (April 1997)
incorporated
UK
address
windrush park, range road, witney, oxon, OX29 0YL
last accounts submitted
December 2022
abbott diabetes care limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We found 3 charges/mortgages relating to abbott diabetes care limited. Currently there are 2 open charges and 1 have been satisfied in the past.
abbott diabetes care limited Companies House Filings - See Documents
| date | description | view/download |
|---|
